Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-09-05
1992-07-28
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546157, 546159, 546172, 546176, 546177, 546178, 546179, 546180, 546256, 546268, 546275, 546283, 546284, 546346, 546149, 546152, 546153, 546155, 549416, 549423, 514249, 514259, 514307, 514311, 514313, 514314, 514336, 544215, 544235, 544237, 544238, 544283, 544284, 544295, 544296, 544333, 544335, 544336, 544353, 544405, A61K 3147, A61K 3144, A61K 31495, C07D40512
Patent
active
051341484
ABSTRACT:
The invention concerns a heterocycle of the formula I ##STR1## wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms;
REFERENCES:
patent: 4567184 (1986-01-01), Musser et al.
patent: 4625034 (1986-11-01), Neiss et al.
patent: 4631287 (1986-12-01), Chakraborty et al.
patent: 4725619 (1988-02-01), Chakraborty et al.
patent: 4728668 (1988-03-01), Chakraborty et al.
patent: 4794188 (1988-12-01), Musser et al.
patent: 4839369 (1989-06-01), Youssefyeh et al.
patent: 4876346 (1989-10-01), Musser et al.
patent: 4918081 (1990-04-01), Huang
patent: 4920130 (1990-04-01), Huang
patent: 4920131 (1990-04-01), Huang
patent: 4920132 (1990-04-01), Huang
patent: 4920133 (1990-04-01), Huang
Journal of Medicinal Chemistry, vol. 30, No. 1, Jan. 1987, pp. 96-106.
Crawley Graham C.
Edwards Philip N.
Girodeau Jean-Marc M. M.
Bernhardt E.
ICI Pharma
Imperial Chemical Industries plc
Shah Mukund J.
LandOfFree
Heterocycles for use as inhibitors of leukotrienes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocycles for use as inhibitors of leukotrienes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycles for use as inhibitors of leukotrienes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1687262